George Tziras - Small Pharma CEO Director
| DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Insider
George Tziras is CEO Director of Small Pharma
| Phone | 44 2071 129118 |
| Web | https://www.smallpharma.com |
Small Pharma Management Efficiency
The company has return on total asset (ROA) of (0.4124) % which means that it has lost $0.4124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7826) %, meaning that it generated substantial loss on money invested by shareholders. Small Pharma's management efficiency ratios could be used to measure how well Small Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Gerry Arambula | Covalon Technologies | N/A | |
| Paul CPA | Mosaic Immunoengineering | 55 | |
| MSc MSc | Cellectis SA | 54 | |
| Simon Smith | Covalon Technologies | N/A | |
| Joseph MPH | Mosaic Immunoengineering | 50 | |
| Cyril Empig | Mosaic Immunoengineering | N/A | |
| Jay Carlson | Mosaic Immunoengineering | N/A | |
| Dr MBA | Cellectis SA | 46 | |
| Elaine Zhang | Covalon Technologies | N/A | |
| Nicole Steinmetz | Mosaic Immunoengineering | 43 | |
| Kyung NamWortman | Cellectis SA | 53 | |
| Marvin MD | Mosaic Immunoengineering | 79 | |
| Valerie Cros | Cellectis SA | N/A | |
| Hamed Abbasian | Covalon Technologies | N/A | |
| Steven King | Mosaic Immunoengineering | 59 | |
| Greg Leszczynski | Covalon Technologies | N/A | |
| Jean Epinat | Cellectis SA | N/A | |
| Jason Gorel | Covalon Technologies | N/A | |
| Mark Doolittle | Covalon Technologies | N/A | |
| Pascalyne Wilson | Cellectis SA | N/A | |
| Ron Hebert | Covalon Technologies | N/A | |
Management Performance
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 |
Small Pharma Leadership Team
Elected by the shareholders, the Small Pharma's board of directors comprises two types of representatives: Small Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Small. The board's role is to monitor Small Pharma's management team and ensure that shareholders' interests are well served. Small Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Small Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarah Hamilton, Group Controller | ||
| LLB HBA, Co Sec | ||
| George Tziras, CEO Director | ||
| David Steel, Chief Officer | ||
| Peter Rands, Founder Officer | ||
| Carol Routledge, Chief Officer | ||
| MD MSc, Chief Officer | ||
| Jenny Maguire, Head Communications | ||
| Emma Hodge, Head Property | ||
| Marie Layzell, Chief Director |
Small Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Small Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 24.67 M | |||
| Shares Outstanding | 321.56 M | |||
| Shares Owned By Insiders | 31.08 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 69,846 X | |||
| Gross Profit | 45 K | |||
| EBITDA | (22.47 M) |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |